Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats

Pharmacological Research

Volumn 45, Issue 4, 2002, Pages 257-263

  Ozer, M K ^a   Sahna, E ^a   Birincioglu, M ^a   Acet, A ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Captopril; Losartan and reperfusion arrhythmias; Necrosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CAPTOPRIL; LOSARTAN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART BEAT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036443977     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2002.0965     Document Type: Article

References (30)

1. Liu YH, Yang XP, Sharov VG, Sigmon DH, Sabbath HN, Carretero OA. Paracrine system in the cardioprotective effect of angiotensin-convertin enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 1996; 27: 7-13.
2. Olmez E, Birincioglu M, Aksoy T, Acet A. Effects of the captopril on ischemia-reperfusion-induced arrhytmias in an in vivo rat model. Pharmacol Res 1995; 32: 37-41.
3. Westlin W, Mullane K. Does captopril attenuate reperfused-induced myocardial dysfunction by scavenging free radical? Circulation 1988; 77: 130-9.
4. van Gilst WH, de Graeff PA, Wesseling H, de Langen CD. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: A comparison of captopril, enalapril and HOE 498. J Cardiovasc Pharmacol 1986; 8: 722-8.
5. Di Pasquale P, Paterna S, Cannizzaro S, Albano V, Valdes L, Licata G, Barone G. Captopril and glutatione before thrombolysis in acute myocardial infarction: Apilot study. Drugs Exp Clin 1992; 18: 401-6.
6. 1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovasc Res 1996; 31: 68-76.
7. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II antagonists. Pharmacol Rev 1993; 45: 205-51.
8. Yoshiyama M et al. Cardioprotective effect of the angiotensin II type I receptors antagonist TCV 116 on ischemia-reperfuion injury. Am Heart J 1994; 128: 1-6.
9. Schwarz ER, Montino H, Fleischhauer J, Klues HG, vom Dahl J, Hanrath P. Angiotensin receptor antagonist EXP3174 reduces infarctt size comparable with enalaprilat and augments preconditioning in the pig heart. Cardiovasc Drugs Ther 1997; 11: 687-95.
10. Zhu B, Sun Y, Sievers RE, Browne AE, Pulukurthy S, Sudhir K, Lee RJ, Chou TM. Chatterjee K, Parmley WW. Comperative effects of pretreatment with captopril and losartan on cardiovascular protection in rats model of ischemia-reperfusion. J Am Coll Cardiol 2000; 35: 787-95.
11. Walker MJ et al. The Lambeth conventions: Guidelines for the study of arrhythmias in ischemia infarction, and reperfusion. Cardiovasc Res 1988; 22: 447-55.
12. Liu Y, Tsuchida A, Cohen MV, Downey JM, Liu Y, Tsuchida A, Cohen MV et al. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbits heart. J Mol Cell Cardiol 1995; 27: 883-92.
13. Noda K, Sasaguri M, Ideishi M, Ikeda M, Arakawa K. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res 1993; 27: 334-40.
14. van Wijngaarden J, Tio RA, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H. Basic pharmacology of ACE-inhibitors with respect to ischemic heart disease: Prostaglandins and bradykinin. Eur Heart J 1990; 11: 84-93.
15. Wiemer G, Scholkens BA, Becker RH, Busse R. Ramiprilat enhanced endothelial autacoid formation by inhibiting breakdown of endothelium-derivated bradykinin. Hypertension 1991; 18: 558-63.
16. Lefer DJ. Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion. New Horiz 1995; 3: 105-12.
17. Entman ML, Smith CW. Postreperfusion inflamation: A model for reaction to injury in cardiovascular disease. Cardiovasc Res 1994; 28: 1301-11.
18. Lucchesi BR, Werms SW, Fantone JC. The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol 1989; 21: 1241-51.
19. Hori M, Gotoh K, Kitakaze M, Iwai K, Iwakura K, Sato H, Koretsune Y, Inoue M, Kitabatake A, Kamada T. Role of oxygen-derived free radicals in myocardial edeme and ischemia in coronary microvascular circulation. Circulaton 1991; 84: 828-40.
20. 1 receptor antagonist irbesartan on ischemia/reperfusion injury in dog heart. Basic Res Cardiol 2000; 95: 404-12.
21. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99: 1926-35.
22. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995; 26: 164-70.
23. 1 angiotensin II receptors abolished ischemic preconditioning in isolated rabit hearts. J Mol Cell Cardiol 1997; 29: 129-39.
24. Hartman JC, Hullinger TG, Wall TM. Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition. Eur J Pharmacol 1993; 234: 229-36.
25. 1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovasc Res 1996; 31: 568-76.
26. Richard V, Ghaled B, Berdeaux A, Giudicelli JF. Comparison of the EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs. Br J Pharmacol 1993; 110: 969-74.
27. Berner M, Hearse DJ. Reperfusion-induced arrhythmias: Mechanisms of protection by glucose and mannitol. Am J Physiol 1988; 254: 862-70.
28. Chopra M, McMurray J, Stewart J, Dargie HJ, Smith WE. Free radical scavenging: A potentially beneficial action of thiolcontaining angiotensin converting enzyme inhibitors. Biochem Soc Trans 1990; 18: 1184-5.
29. Thandroyen FT, McCarthy J, Burton KP, Opie LH. Ryanodine and caffeine prevent ventricular arrhythmias during acut myocardial ischemia and reperfusion in rat heart. Circ Res 1988; 62: 306-14.
30. Matsuo K, Kumagai K, Annoura M, Yamanouchi Y, Handa K, Nakashima y, Hiroki T, Arakawa K. Effects of an angiotensin II antagonist on reperfusion arrhythmias in dogs. Pacing Clin Elektropphysiol 1997; 20: 938-45.